Abstract
Thrombotic thrombocytopenic purpura (TTP) is a severe and potentially fatal syndrome increasingly reported shortly after allogeneic bone marrow transplantation. We report a 49-year-old patient who developed a recurrent and ultimately fatal form of TTP late after autotransplant for chronic myeloid leukemia.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lugassy, G., Ducach, A. & Blumenthal, R. Fatal chronic relapsing thrombotic thrombocytopenic purpura following autologous bone marrow transplantation for chronic myeloid leukemia. Bone Marrow Transplant 21, 859–860 (1998). https://doi.org/10.1038/sj.bmt.1701171
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1701171
- Springer Nature Limited
Keywords
This article is cited by
-
Renal thrombotic microangiopathy and podocytopathy associated with the use of carfilzomib in a patient with multiple myeloma
BMC Nephrology (2014)
-
Plasma exchange as successful treatment of thrombotic thrombocytopenic purpura post autologous bone marrow transplant in a child
Bone Marrow Transplantation (2000)